NOWDiagnostics Secures $22.5 Million to Revolutionize At-Home Testing
NOWDiagnostics, Inc. (NOWDx), a pioneering developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, has announced a significant milestone with the successful closure of a $22.5 million Series B financing round. Led by DigitalDx Ventures, alongside strategic investments from the Labcorp Venture Fund and Kompass Kapital Management, this funding is set to propel NOWDx to…